◆
BLACKSPECTER
AI Chat öffnen →
BlackSpecter
›
Aktien
›
AZN
AZN
(AZN)
Kennzahlen
Marktkapitalisierung
n/a
KGV (TTM)
n/a
Umsatz (TTM)
n/a
EBITDA
n/a
Dividendenrendite
n/a
52W Hoch
n/a
52W Tief
n/a
Beta
n/a
EPS (TTM)
n/a
Forward KGV
n/a
PEG Ratio
n/a
Short-Quote
n/a
Analysten-Ratings
Keine Analysten-Daten verfügbar
Earnings
Keine Earnings-Daten verfügbar
Aktuelle News
Motley Fool
·
vor 18 Std.
Opinion: Bristol Myers Squibb Is a Buy -- but the Real Reason Why Might Surprise Investors
Stocktwits
·
vor 1 Tagen
IONS, AZN Stocks Fall On Full Data From Failed Cardiomyopathy Trial — Jefferies Sees Neutral To Negative Readthrough To ALNY
Zacks
·
vor 1 Tagen
SNY Stock Trading Above 50- & 200-Day SMAs: Buy, Hold or Sell?
Investing.com
·
vor 1 Tagen
Alnylam stock drops on rival heart trial: Why analysts see core business safe
BioPharma Dive
·
vor 1 Tagen
AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease
GlobeNewswire
·
vor 2 Tagen
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
Frag BlackSpecter AI über AZN
Earnings-Analyse, Bewertungs-Check, Peer-Vergleich — in Sekunden.
Ist AZN kaufenswert?
AZN Earnings Analyse
AZN Bewertung
AI Chat öffnen →